MDH2 and breast carcinoma: Our molecular modeling studies suggest that the MDH2 variant found in recurrent breast cancer cases may lead to lower [NADH] and elevated NAD+, reducing oxygen consumption and ATP production during the mitochondrial respiration cycle—or, in other words, augmentation of anerobic glycolysis, which has been found to contribute to cancer cell proliferation [31,32].